Navigation Links
Nventa's CEO to present at two upcoming investor conferences
Date:10/2/2007

SAN DIEGO, CA, Oct. 2 /PRNewswire-FirstCall/ - Nventa Biopharmaceuticals Corporation (TSX:NVN) announced today that Gregory M. McKee, the Company's President and Chief Executive Officer, will present at two upcoming investor conferences:

BioContact Quebec 2007 (Quebec, Canada):

----------------------------------------

Mr. McKee is scheduled to present on Thursday, October 4th at

11:00 am (Eastern Time) in the Salle Laval Room at the Fairmont Le

Chateau Frontenac.

BIO Investor Forum (San Francisco, California):

-----------------------------------------------

Mr. McKee is scheduled to present on Wednesday, October 10th at

1:15 pm (Pacific Time) in the Twin Peaks South Room at the Palace

Hotel in San Francisco. A live webcast with supporting slides of this

presentation will be available via:

http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=NVN.TO&item_id=1660569

The replay of the webcast at BIO Investor Forum will be available

until January 10, 2008. (Due to its length, this URL may need to be

copied/pasted into your Internet browser's address field. Remove any

extra spaces if necessary.)

About Nventa Biopharmaceuticals Corporation:

--------------------------------------------

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Exchange under the symbol NVN.

For more information about Nventa Biopharmaceuticals Corporation and access to the BIO Investor Forum webcast, please visit the Company's website located at http://www.nventacorp.com.

CONTACT: Donna Slade, Director, Investor Relations, 9381 Judicial Drive, Suite 180, San Diego, CA USA 92121, Tel: (858) 202-4945, Fax: (858) 450-6849, dslade@nventacorp.com


'/>"/>
SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 2017   Parent Project Muscular Dystrophy (PPMD) , ... Duchenne muscular dystrophy (Duchenne) , today announced a $600,000 ... of Technology (NJIT) and Talem Technologies (Talem) as part ... to assist people living with Duchenne. PPMD is ... an embedded computer, software, a force sensor and a ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, ... Stream, NY. The procedure was an anterior cervical discectomy and fusion on a ...
(Date:1/18/2017)... Frederick, Maryland (PRWEB) , ... January 18, 2017 ... ... of two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of ... Innovation in Manufacturing Biopharmaceuticals (NIIMBL), and the Department of Defense has announced the ...
(Date:1/18/2017)... ... , ... Researchers from a new study are stating that if levels of the ... treatment, this indicates there is still remaining prostate cancer cells that are more likely to ... has always been an indicator of whether a man’s prostate cancer is growing or ...
Breaking Biology Technology:
(Date:12/16/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The biometric vehicle access system market, in terms ... from 2016 to 2021. The market is estimated to be USD ... by 2021. The growth of the biometric vehicle access system market ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
Breaking Biology News(10 mins):